Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy

Authors


Young Hee Yoon, MD
Professor of Ophthalmology
Department of Ophthalmology
University of Ulsan
Asan Medical Center
#388-1 Poongnap-dong
Songpa-gu
Seoul
Korea Zip code 138-736
Tel: 82 02 3010 3675
Fax: 82 02 470 6440
Email: yhyoon@amc.seoul.kr

No abstract is available for this article.

Ancillary